Latest news
XOMA Royalty Corporation Earnings and Revenue – MUN:US98419J206 - TradingViewTradingView · Mon, 10 Aug 2026 05:50:59 GMTLigand Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 21:03:55 GMTLGND: Q2 2026 revenue up 34% YoY, net income $48.5M, XOMA acquisition doubled royalty portfolio - TradingViewTradingView · Thu, 06 Aug 2026 20:09:12 GMTLGND: Q2 2026 delivered record royalty growth, XOMA integration, and robust guidance for continued expansion - TradingViewTradingView · Thu, 06 Aug 2026 15:56:41 GMTLGND: Q2 2026 delivered strong revenue and EPS growth, fueled by the XOMA acquisition and robust royalty gains - TradingViewTradingView · Thu, 06 Aug 2026 14:48:23 GMTLGND: Q2 2026 royalty revenue up 32%, adjusted EPS guidance raised after XOMA acquisition and debt financing - TradingViewTradingView · Thu, 06 Aug 2026 12:28:27 GMTLGND: Q2 2026 delivered strong royalty and EPS growth, with XOMA acquisition doubling the portfolio - TradingViewTradingView · Thu, 06 Aug 2026 11:34:47 GMTLigand reports Q2 2026: Revenue $63.7M, Royalties $48.0M, GAAP EPS $2.22, Adjusted EPS $2.37 - TradingViewTradingView · Thu, 06 Aug 2026 11:13:01 GMT